Figure 5
Design of the phase IV, randomized, open-label, active-controlled, 2-arm, multicenter ZIPANGU study. BL baseline, EOT end of treatment, EOS end of the study, M month, S screening.
Figure 5 | Scientific Reports
Design of the phase IV, randomized, open-label, active-controlled, 2-arm, multicenter ZIPANGU study. BL baseline, EOT end of treatment, EOS end of the study, M month, S screening.
